MD2700C2 - Process for obtaining of 5a-furostan-3B,22,26-triol-3-[O-B-D-glucopyranosyl (1→2)-B-D-glucopyranosyl(1→4)-B-D-galactopyranosyl]-26-O-B-D-glucopyranoside (pacoverine) - Google Patents

Process for obtaining of 5a-furostan-3B,22,26-triol-3-[O-B-D-glucopyranosyl (1→2)-B-D-glucopyranosyl(1→4)-B-D-galactopyranosyl]-26-O-B-D-glucopyranoside (pacoverine)

Info

Publication number
MD2700C2
MD2700C2 MDA20040166A MD20040166A MD2700C2 MD 2700 C2 MD2700 C2 MD 2700C2 MD A20040166 A MDA20040166 A MD A20040166A MD 20040166 A MD20040166 A MD 20040166A MD 2700 C2 MD2700 C2 MD 2700C2
Authority
MD
Moldova
Prior art keywords
glucopyranosyl
pacoverine
furostan
galactopyranosyl
glucopyranoside
Prior art date
Application number
MDA20040166A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD2700B1 (en
Inventor
Константин СПЫНУ
Павел КИНТЯ
Original Assignee
Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова filed Critical Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова
Priority to MDA20040166A priority Critical patent/MD2700C2/en
Publication of MD2700B1 publication Critical patent/MD2700B1/en
Publication of MD2700C2 publication Critical patent/MD2700C2/en

Links

Abstract

The invention refers to medicine, in particular to the pharmaceutical industry.Summary of the invention consists in that the process for obtaining of 5α-furostan-3β,22,26-triol-3-[O-β-D-glucopyranosyl(1→2)-β-D-glucopyranosyl(1→4) -β-D-galactopyranosyl]-26-O-β-D-glucopyranoside (pacoverine) includes treatment by boiling of tomato seeds in n-butanol, with subsequent evaporation thereof and washing of the obtained residue with a solution of chloroform and acetone, taken in the ratio of 1:1, filtration, afterwards the residue is repeatedly filter washed with acetone and dried.
MDA20040166A 2004-07-01 2004-07-01 Process for obtaining of 5a-furostan-3B,22,26-triol-3-[O-B-D-glucopyranosyl (1→2)-B-D-glucopyranosyl(1→4)-B-D-galactopyranosyl]-26-O-B-D-glucopyranoside (pacoverine) MD2700C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20040166A MD2700C2 (en) 2004-07-01 2004-07-01 Process for obtaining of 5a-furostan-3B,22,26-triol-3-[O-B-D-glucopyranosyl (1→2)-B-D-glucopyranosyl(1→4)-B-D-galactopyranosyl]-26-O-B-D-glucopyranoside (pacoverine)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20040166A MD2700C2 (en) 2004-07-01 2004-07-01 Process for obtaining of 5a-furostan-3B,22,26-triol-3-[O-B-D-glucopyranosyl (1→2)-B-D-glucopyranosyl(1→4)-B-D-galactopyranosyl]-26-O-B-D-glucopyranoside (pacoverine)

Publications (2)

Publication Number Publication Date
MD2700B1 MD2700B1 (en) 2005-02-28
MD2700C2 true MD2700C2 (en) 2005-10-31

Family

ID=34374317

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20040166A MD2700C2 (en) 2004-07-01 2004-07-01 Process for obtaining of 5a-furostan-3B,22,26-triol-3-[O-B-D-glucopyranosyl (1→2)-B-D-glucopyranosyl(1→4)-B-D-galactopyranosyl]-26-O-B-D-glucopyranoside (pacoverine)

Country Status (1)

Country Link
MD (1) MD2700C2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD20060037A (en) * 2006-01-24 2007-07-31 Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова Method of treating the acute viral hepatitis C
MD3446G2 (en) * 2006-09-21 2008-10-31 Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова Method of HIV infection treatment

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1314642A1 (en) * 1985-05-14 1995-08-27 Институт экологической генетики АН МССР Chemical immunizer of tobacco against virus of tobacco bronzite
MD385C2 (en) * 1994-12-28 1996-06-30 Научно-исследовательский конструкторско-технологический институт табака и табачных изделий Tobacco chemical immunizer to the tobacco tronzing virus

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1314642A1 (en) * 1985-05-14 1995-08-27 Институт экологической генетики АН МССР Chemical immunizer of tobacco against virus of tobacco bronzite
MD385C2 (en) * 1994-12-28 1996-06-30 Научно-исследовательский конструкторско-технологический институт табака и табачных изделий Tobacco chemical immunizer to the tobacco tronzing virus

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD20060037A (en) * 2006-01-24 2007-07-31 Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова Method of treating the acute viral hepatitis C
MD3446G2 (en) * 2006-09-21 2008-10-31 Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова Method of HIV infection treatment

Also Published As

Publication number Publication date
MD2700B1 (en) 2005-02-28

Similar Documents

Publication Publication Date Title
El-Sherei et al. Phytochemistry, biological activities and economical uses of the genus Sterculia and the related genera: A reveiw
NO20051084L (en) Extract of Echinacea Angustifolia
JP5996027B2 (en) Lozenge and method for producing the same
Kim et al. The potential use of citrus juice waste as sources of natural phenolic antioxidants
Hashemi et al. Evaluation of three methods for the extraction of antioxidants from vicia faba L. bean and hulls
CN1961762A (en) Sargassum fusiforme alcohol extract and application thereof in tobacco
MD2700C2 (en) Process for obtaining of 5a-furostan-3B,22,26-triol-3-[O-B-D-glucopyranosyl (1→2)-B-D-glucopyranosyl(1→4)-B-D-galactopyranosyl]-26-O-B-D-glucopyranoside (pacoverine)
CN109293791A (en) Lepista mucla (Bull.:Fr.) Cooke water-soluble polysaccharide and the preparation method and application thereof
Prasad et al. 10 High Pressure–Assisted Extraction: Method, Technique, and Application
Jan et al. Effect of crude extract of Raphanus sativus roots on isolated trachea of albino rat
CN1806646A (en) Lily tea with health-preserving function
CN105250207B (en) A kind of pure natural components agalloch eaglewood ant nest fruit facial mask liquid, facial mask and preparation method thereof
MD2037G2 (en) Process for obtaining the 22-O-hydroxyfurostanols
Ethiraj et al. Phytochemical screening, antioxidant activity and extraction of active compound (Anonaine) from fruit peel extract of Annona reticulata L
CN104761652A (en) Technology for extracting polysaccharides from banana peel
CN106109519A (en) One panax species safely and efficiently and preparation technology thereof
Amin Mir et al. Anti Urolithiatic and Anti-Arthritis Activity of Various Extracts of Ganoderma lucidum
CN106038697B (en) Method for extracting and purifying alkaloid in litsea cubeba flowers and stems
Luigia et al. 14th International Conference on the Chemistry of Selenium and Tellurium ICCST-14 (3rd-7th June 2019)
WO2008056388A8 (en) Drug based on ozonized terpenes or terpene-derivatives, processes for producing it and uses thereof
RU2007142179A (en) ANTIALLERGENIC LATEX OR PVC PRODUCTS AND METHODS FOR THEIR MANUFACTURE
ES2324584A1 (en) Pharmaceutical Formulation for Treatment of Acquired Immune Deficiency Syndrome (AIDS).
GB2441902A (en) Novel method for preparing ginseng to obtain increased amount of ginsenoside RG5
MD2004G2 (en) Process for obtaining of furastanolic glycosides
Kubra et al. Green synthesis of silver and gold nanoparticles using Crataegus oxyacantha extract and their urease inhibitory activities

Legal Events

Date Code Title Description
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees